Show Summary Details
Page of

Peripartum Cardiomyopathy 

Peripartum Cardiomyopathy
Peripartum Cardiomyopathy

Emily J. Baird

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2021. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 19 June 2021

Peripartum cardiomyopathy (PPCM) is an idiopathic form of heart failure that manifests during the last month of pregnancy or the first 5 months postpartum. Although the incidence is relatively low, the maternal impact is high, with up to 12% of maternal deaths in the United States resulting from sequelae of PPCM. Risk factors are poorly understood at the present time, as are the pathophysiologic mechanisms. Timely diagnosis continues to be a challenge, since many of the symptoms of PPCM mimic those commonly encountered during the normal peripartum period. Management of PPCM parallels current heart failure guidelines, with special consideration to the safety of medications and interventions during pregnancy and lactation. This chapter discusses proper clinical suspicion, processes for diagnosis, and current treatment strategies as well as the overall prognosis.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.